Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.
about
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer CellsImplications of the Hybrid Epithelial/Mesenchymal Phenotype in MetastasisStructural and Functional Studies on the Interaction of Adenovirus Fiber Knobs and Desmoglein 2Epimorphin-induced MET sensitizes ovarian cancer cells to platinumControl of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells.Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.EMT and MET: necessary or permissive for metastasis?Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer DisseminationMetformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.Towards elucidating the connection between epithelial-mesenchymal transitions and stemnessStability of the hybrid epithelial/mesenchymal phenotype.Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation.Microfluidic device for mechanical dissociation of cancer cell aggregates into single cellsPenton-dodecahedral particles trigger opening of intercellular junctions and facilitate viral spread during adenovirus serotype 3 infection of epithelial cells.Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyStemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival.Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin.The traditional Tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migrationRegulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityLysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.Long-term primary culture of a clear cell ovarian carcinoma reveals an epithelial-mesenchymal cooperative interaction.Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells.Population Heterogeneity in the Epithelial to Mesenchymal Transition Is Controlled by NFAT and Phosphorylated Sp1.Coupling the modules of EMT and stemness: A tunable 'stemness window' modelTransformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftmentDistinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxelThe peritoneal tumour microenvironment of high-grade serous ovarian cancer.Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor ModelsA 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion.Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays.Aiming to immune elimination of ovarian cancer stem cellsAn EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).Expression and clinical significance of colorectal cancer stem cell marker EpCAM(high)/CD44(+) in colorectal cancer.
P2860
Q26738643-1C4C173A-A7E1-42A2-9615-28AC92E000CCQ26799987-7394F8ED-8477-49BB-A3C9-2FEEAE3B6930Q27679683-CD151980-B3C6-411F-AB31-551D6FBC737FQ28536991-EA280589-BF2C-43F7-A2BF-5877EA8BA520Q33676231-E07E4765-042F-44C1-BE36-291600A811DBQ33869770-98C20C1B-7448-4E84-8CDE-789B1B5C3DE4Q33869775-11C37FEB-F46C-4B3A-97C3-2B3A5B25C843Q33872469-5DA2868B-4BBC-409E-9623-C8E209F6A346Q33890763-45A9643B-9F4B-4926-A932-511033A89B24Q34042603-1AB9C75D-46AB-4D95-8852-44C5D4CCF3E1Q34383397-9BF371F5-4069-4DC4-9961-9947DD7D82B6Q34470537-9BCAC51A-A10A-4302-ACC9-1D06AF48A852Q34519552-4FBF7FF3-41A1-45FB-B884-F7BCBB99443CQ34796781-3F02E283-4437-4499-96DA-D173B136B020Q34994195-F0EA21F2-72FA-44DB-8E2D-1E8C54F127DAQ35034232-AA1080E7-0E4C-4F53-842C-A7524B741C44Q35142842-DA601FFA-87FB-4E22-80AE-8592243E2A41Q35540959-9D48AD88-4314-4169-8726-4FFA3DC707D1Q35543094-B306243F-CF67-4FAE-98C2-3762CFC87822Q35644828-571A6A5B-76C7-4173-82AE-A7AA53EDE29CQ35651085-E56CD248-91D1-4708-950B-262E2AF74CE3Q35662679-6CC79A0B-A0BD-4D40-A189-7C72F99003FCQ35837949-95AD3883-4CC5-4DBA-9284-F2AF12A3734CQ35879981-DCC8B22A-BE81-429A-AD15-C6967146059DQ35939439-FB777135-A89F-45B2-9F2D-076F7F90E334Q36014411-B8E7979A-4FA4-45DC-BD52-E2CB21D27078Q36065252-C9A02694-5232-4A9D-8B6F-26C23F7139EFQ36088162-CB2C7D4C-F45C-4D78-AA9F-47D2B92C15C6Q36116632-D6AA9E8A-DC93-4DB8-932B-2DF7B5F34589Q36233870-8DC44FE4-ED82-4EFE-8041-5133962C1218Q36413140-AE33E9D0-E8A7-4D4A-A108-782F70BD98CDQ36434358-1023DA41-5BAD-4B94-9AB6-CF9C7EF634DDQ36521792-EB2447F3-3036-46BB-A61F-72E6F8FF82E1Q36719074-93C84F9D-4C66-45E8-B84F-EF1E18509C38Q36825407-F9CFA352-77DA-4BBB-AC19-BEFABEC3D481Q36965198-2CF1BE67-1197-4595-A2BF-3D0C9510FFEAQ37214262-62CB4BEB-F56A-4863-9DB3-2725BC431EB1Q37266548-28F846BE-A2DC-4EFE-A5DB-E8726206DE66Q37357076-8A6E6E5C-D679-4039-A748-6364A23846FBQ37720008-D4238D99-F9DE-4BBA-B6A0-CBB3B0145365
P2860
Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Analysis of epithelial and mes ...... heterogeneity and plasticity.
@ast
Analysis of epithelial and mes ...... heterogeneity and plasticity.
@en
type
label
Analysis of epithelial and mes ...... heterogeneity and plasticity.
@ast
Analysis of epithelial and mes ...... heterogeneity and plasticity.
@en
prefLabel
Analysis of epithelial and mes ...... heterogeneity and plasticity.
@ast
Analysis of epithelial and mes ...... heterogeneity and plasticity.
@en
P2093
P2860
P1433
P1476
Analysis of epithelial and mes ...... heterogeneity and plasticity.
@en
P2093
André Lieber
Charles Drescher
Ines Beyer
Jonas Persson
Nicole Urban
Pavel Sova
Petra Hamerlik
Robert Strauss
Sari Pesonen
Thomas Möller
P2860
P304
P356
10.1371/JOURNAL.PONE.0016186
P407
P577
2011-01-14T00:00:00Z